Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy

被引:60
|
作者
Di Costanzo, Alessia [1 ]
Belardinilli, Francesca [2 ]
Bailetti, Diego [3 ]
Sponziello, Marialuisa [1 ]
D'Erasmo, Laura [1 ]
Polimeni, Licia [1 ]
Baratta, Francesco [1 ,4 ]
Pastori, Daniele [1 ,4 ]
Ceci, Fabrizio [5 ]
Montali, Anna [1 ]
Girelli, Gabriella [6 ]
De Masi, Bruna [6 ]
Angeloni, Antonio [2 ]
Giannini, Giuseppe [2 ]
Del Ben, Maria [1 ]
Angelico, Francesco [7 ]
Arca, Marcello [1 ]
机构
[1] Sapienza Univ, Dept Internal Med & Med Specialties, Rome, Italy
[2] Sapienza Univ, Dept Mol Med, Rome, Italy
[3] Sapienza Univ, Dept Expt Med, Rome, Italy
[4] Sapienza Univ, Dept Anat Histol Forens Med & Ortoped Sci, Rome, Italy
[5] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
[6] Sapienza Univ, Immunohematol & Transfus Med Unit, Rome, Italy
[7] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
GENOME-WIDE ASSOCIATION; SUPERFAMILY MEMBER 2; CONFERS SUSCEPTIBILITY; VARIANT; RISK; PNPLA3; SEVERITY; MBOAT7; TM6SF2; STEATOHEPATITIS;
D O I
10.1038/s41598-018-21939-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NAFLD is a polygenic condition but the individual and cumulative contribution of identified genes remains to be established. To get additional insight into the genetic architecture of NAFLD, GWAS-identified GCKR, PPP1R3B, NCAN, LYPLAL1 and TM6SF2 genes were resequenced by next generation sequencing in a cohort of 218 NAFLD subjects and 227 controls, where PNPLA3 rs738409 and MBOAT7 rs641738 genotypes were also obtained. A total of 168 sequence variants were detected and 47 were annotated as functional. When all functional variants within each gene were considered, only those in TM6SF2 accumulate in NAFLD subjects compared to controls (P = 0.04). Among individual variants, rs1260326 in GCKR and rs641738 in MBOAT7 (recessive), rs58542926 in TM6SF2 and rs738409 in PNPLA3 (dominant) emerged as associated to NAFLD, with PNPLA3 rs738409 being the strongest predictor (OR 3.12, 95% CI, 1.8-5.5, P < 0.001). A 4-SNPs weighted genetic risk score value > 0.28 was associated with a 3-fold increased risk of NAFLD. Interestingly, rs61756425 in PPP1R3B and rs641738 in MBOAT7 genes were predictors of NAFLD severity. Overall, TM6SF2, GCKR, PNPLA3 and MBOAT7 were confirmed to be associated with NAFLD and a score based on these genes was highly predictive of this condition. In addition, PPP1R3B and MBOAT7 might influence NAFLD severity.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [42] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [43] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290) : 2212 - 2224
  • [44] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210
  • [45] Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
    Jang, Yun Seo
    Joo, Hye Jin
    Park, Yu Shin
    Park, Eun-Cheol
    Jang, Sung-In
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [46] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [47] Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)
    Teufel, Andreas
    Geier, Andreas
    Sarrazin, Christoph
    Schattenberg, Joern M.
    Kautz, Achim
    Dorner, Rebecca
    Kramer, Jan
    Jerysiak, Katrin
    Baars, Theodor
    Hoenscheid, Bastian
    Mueller-Wieland, Dirk
    Rossol, Siegbert
    Trautwein, Christian
    Tacke, Frank
    Canbay, Ali
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (08): : 1028 - 1036
  • [48] A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Racila, Andrei
    Lam, Brian
    Pham, Huong T.
    Hunt, Sharon
    LIVER INTERNATIONAL, 2017, 37 (08) : 1209 - 1218
  • [49] Challenges in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD): Towards a Compassionate Approach
    Shea, Sue
    Lionis, Christos
    Kite, Chris
    Atkinson, Lou
    Lagojda, Lukasz
    Chaggar, Surinderjeet S.
    Kyrou, Ioannis
    Randeva, Harpal S.
    LIVERS, 2023, 3 (03): : 434 - 447
  • [50] Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents
    Ferraz de Assuncao, Silvana Neves
    Amaral Boa Sorte, Ney Christian
    Dantas Alves, Cresio de Aragao
    Almeida Mendes, Patricia S.
    Brites Alves, Carlos Roberto
    Silva, Luciana Rodrigues
    NUTRICION HOSPITALARIA, 2018, 35 (01) : 78 - 83